Prof Andrew Kneebone
/content/dam/asset-migration/headshots/au-doctor-headshots/AU_Oncology_Headshot_GA_Prof Andrew Kneebone.jpg

Prof. Andrew Kneebone

Prof. Andrew Kneebone
MBBS, FRANZCR, Radiation Oncologist

Languages spoken


Expert in

Gastrointestinal and genitourinary and cancers.



Mater Hospital, Sydney (Oncology)
Mater Hospital, Sydney (Oncology)

The Mater Hospital, 25 Rocklands road, North Sydney, NSW

-33.83166139694626, 151.20156682718073
Macquarie University Hospital (Oncology)
Macquarie University Hospital (Oncology)

Hospital Building, Suite 1, Level B2, 3 Technology Place, Macquarie University, NSW, 2109

-33.77308982351843, 151.11793004035897
North Shore
North Shore

North Shore Health Hub, Tower A, Level 1, 7 Westbourne Street, St Leonards NSW 2065, Australia

-33.82024297423824, 151.19062046149045

Specialises in

Gastrointestinal cancer
Condition/Cancer/Gastrointestinal Cancer
Genitourinary cancer
Condition/Cancer/Genitourinary Cancer
Prostate cancer
Condition/Cancer/Prostate Cancer


Radiation therapy
Service/Cancer/Radiation Oncology
Service/Cancer/Radiation Oncology/Radiation Therapy

Special clinical interests in gastrointestinal and genitourinary cancers.

Andrew is a leader in radiation oncology, with over 20 years experience as a gastrointestinal and genitourinary cancer specialist.

Andrew is a passionate and energetic clinician who’s committed to building caring and honest relationships with his patients. His experience and insight makes him the doctor many patients in Sydney turn to when they want a second opinion knowing they are seeing one of Australia’s leading specialists in his field.


Andrew has been awarded the Denise Lonergan award by the Royal Australian and New Zealand College of Radiologists (RANZCR) for outstanding commitment, participation and leadership in training and education for radiation oncology.

Clinical and research interests

Andrew is a committed teacher for medical students and junior doctors. He lectures at the University of Sydney and has been the Director of Registrar Training for more than 20 years.

Andrew is a leading researcher with more than 140 peer reviewed publications and is the chief investigator in several important NHMRC funded National clinical trials in prostate and pancreatic cancer.

Professional memberships

Andrew has been an invited speaker at more than 90 conferences or meetings, and has served on numerous state and national committees on cancer management.

Andrew has been the chair of both the national Radiation Oncology Genitourinary executive (FROGG) and the Radiation Oncology Executive for the Australian Gastro-Intestinal Trials Group (AGITG). He’s also served on the National Board of the Prostate Cancer Foundation of Australia and has been made an Honorary Life member.


Andrew’s reputation as one of the country’s leading radiation oncologists is built upon his leading role in writing published national guidelines for prostate cancer (both for radiation alone and following a prostatectomy), bladder cancer, anal cancer, and pancreatic cancer.